| 引用本文: |
黄蓉,陈磊,席晓宇.抗肿瘤药物经济学评价生存数据外推国际规范及我国研究现状*[J].中国卫生经济,2023,42(11):61-65.[点击复制] |
Huang Rong,Chen Lei,Xi Xiaoyu.Extrapolation International Standard of Survival Data for Economic Evaluation of Antitumor Drugs and Its Research Status in China[J].CHINESE HEALTH ECONOMICS,2023,42(11):61-65.[点击复制] |
|
| 摘要: |
| 生存数据外推在抗肿瘤药物经济学评价中发挥着至关重要的作用，但我国药物经济学评价指南尚未对生存数据外推进行规范。文章梳理国际生存数据外推相关规范及我国抗肿瘤药物经济学评价生存数据外推研究现状，以期为我国生存数据外推向规范化发展提供参考建议。 |
| 关键词: 生存分析 数据外推 参数模型 药物经济学评价 |
| DOI： |
| 投稿时间：2023-08-17 |
| 基金项目:江苏高校哲学社会科学研究基金资助项目 （2019SJA0062） |
|
| Extrapolation International Standard of Survival Data for Economic Evaluation of Antitumor Drugs and Its Research Status in China |
| Huang Rong,Chen Lei,Xi Xiaoyu |
| (China Pharmaceutical University, Nanjing, 211198 , China) |
| Abstract: |
| Extrapolation of survival data plays a vital role in the evaluation of anti-tumor pharmacoeconomics, but it has not been standardized in the evaluation guide of pharmacoeconomics in China. It aims to sort out the relevant international norms of extrapolation of survival data and clarify the current research situation of extrapolation of survival data in the economic evaluation of antitumor drugs in China, in order to provide reference suggestions for the more standardized development of extrapolation of survival data in China. |
| Key words: survival analysis data extrapolation parametric model pharmacoeconomic evaluation |
